The IonFlux Automated Patch Clamp System

Patch clamp assays have never been easier!

By integrating microfluidic perfusion with standard well plates, Fluxion has produced automated electrophysiology systems that look and operate much like a benchtop microplate reader. The IonFlux systems have made patch clamping simpler, faster and better than ever before. From the broadest range of protocols, to the richest set of features, the IonFlux systems will satisfy users with a demanding need for high fidelity data and those who need it easily.

 
  • Choose true giga-ohm seal performance or consistent ensemble recording, all on the same system.

  • Continuous perfusion is a system standard - just like a manual rig! The ideal system for ligand- gated ion channels.

  • Automated temperature control - run from 4º to 40º C. 

  • 2 configurations to meet the broadest range of needs, from most affordable system to highest throughput of 10,000 or more data points per day.

  • Affordable - prices starting at the same level as a manual patch clamp rig. 

  • Scalable - can be integrated with a liquid handler for walk-away automation. 






                                                                                                            



  
I need to add electrophysiology  
capabilities to my lab.”
Discover how the Arnold lab at UW 
quickly developed a transient 
transfection ion channel assay 

>> view the presentation

   


 “I need continuous perfusion to 
perform 
a successful NMDA assay.”
Discover what continuous perfusion 
and 
synchronous operation can do for 
one of the most challenging LGIC targets. 
100% agonist 
exchange and no wait time 
between compound 
additions make all the 
difference 

 >> view the data compilation

   
I need to increase my ion channel 
compound screening throughput 
and 
 
success rate to the next level.”
See how Pfizer scientists supercharged
their LGIC assays, dramatically 
increasing 
throughput and reducing 
cost

>> view the webinar

  
    

I need a better hERG safety assay. My 
current 
solution has low success rates 
and high
  
consumable costs.”

Review data on key reference compounds
and the 
Novartis publication detailing hERG 
performance 
and pharmacology, including 
physiological temperature 
studies 

>> view the abstract